More studies in progress advise that ARV-825 may additionally be effective in enhancing the reaction to estrogen deprivation (aromatase inhibition), another part of standard of treatment in ER+ breast cancer. 88 These preclinical studies give paradigms for long term clinical trials in AML, and th